Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Hutter

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Blood Advances|July 28, 2023
Interplay of TP53 allelic state, blast count, and complex karyotype on survival of patients with AML and MDSAnna Stengel, Manja Meggendorfer, Wencke Walter, et al.
Blood Neoplasia|September 23, 2025
<i>SRSF2</i> mutations in CCUS, MDS and AML: a cross-entity studySandra Huber, Sarah Ochmann, Stephan Hutter, et al.
Plos One|September 1, 2009
The transcriptional response of Drosophila melanogaster to infection with the sigma virus (Rhabdoviridae)Jennifer Carpenter, Stephan Hutter, John F Baines, et al.
Leukemia|June 19, 2019
DNMT3A mutations are over-represented in young adults with NPM1 mutated AML and prompt a distinct co-mutational patternLuca Vincenzo Cappelli, Manja Meggendorfer, Frank Dicker, et al.
Leukemia|April 29, 2023
AML classification in the year 2023: How to avoid a Babylonian confusion of languagesSandra Huber, Constance Baer, Stephan Hutter, et al.
Leukemia|December 3, 2022
Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblastsSandra Huber, Torsten Haferlach, Manja Meggendorfer, et al.
Journal of Clinical Laboratory Analysis|June 8, 2026
Not Missing the Notch: Detection Challenges of Juxtamembrane NOTCH1 Variant Detection in T-Cell Acute Lymphoblastic LeukemiaFrancisco Beas, Stephan Hutter, Ferran Balbastre-Úbeda, et al.
Leukemia|August 12, 2023
Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICCSandra Huber, Constance Baer, Stephan Hutter, et al.
Biomedical Reports|March 21, 2014
Detection of circulating tumour cells on mRNA levels with established breast cancer cell linesMichael Zebisch, Alexandra C Kölbl, Ulrich Andergassen, et al.
Leukemia|May 10, 2024
Genomic landscape of CCUS compared to MDS and its implications on risk predictionSandra Huber, Constance Baer, Stephan Hutter, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Blood Advances|July 28, 2023
Interplay of TP53 allelic state, blast count, and complex karyotype on survival of patients with AML and MDSAnna Stengel, Manja Meggendorfer, Wencke Walter, et al.
Blood Neoplasia|September 23, 2025
<i>SRSF2</i> mutations in CCUS, MDS and AML: a cross-entity studySandra Huber, Sarah Ochmann, Stephan Hutter, et al.
Plos One|September 1, 2009
The transcriptional response of Drosophila melanogaster to infection with the sigma virus (Rhabdoviridae)Jennifer Carpenter, Stephan Hutter, John F Baines, et al.
Leukemia|June 19, 2019
DNMT3A mutations are over-represented in young adults with NPM1 mutated AML and prompt a distinct co-mutational patternLuca Vincenzo Cappelli, Manja Meggendorfer, Frank Dicker, et al.
Leukemia|April 29, 2023
AML classification in the year 2023: How to avoid a Babylonian confusion of languagesSandra Huber, Constance Baer, Stephan Hutter, et al.
Leukemia|December 3, 2022
Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblastsSandra Huber, Torsten Haferlach, Manja Meggendorfer, et al.
Journal of Clinical Laboratory Analysis|June 8, 2026
Not Missing the Notch: Detection Challenges of Juxtamembrane NOTCH1 Variant Detection in T-Cell Acute Lymphoblastic LeukemiaFrancisco Beas, Stephan Hutter, Ferran Balbastre-Úbeda, et al.
Leukemia|August 12, 2023
Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICCSandra Huber, Constance Baer, Stephan Hutter, et al.
Biomedical Reports|March 21, 2014
Detection of circulating tumour cells on mRNA levels with established breast cancer cell linesMichael Zebisch, Alexandra C Kölbl, Ulrich Andergassen, et al.
Leukemia|May 10, 2024
Genomic landscape of CCUS compared to MDS and its implications on risk predictionSandra Huber, Constance Baer, Stephan Hutter, et al.
Pageof 8